Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AMNESIA”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,639 records · Page 91Linked to original sources

Amnesia for arithmetic facts: a single case study.

We report the case of an anarithmetic patient with a selective deficit of memory for elementary arithmetic facts, who produced, for instance, "25" in answer to "4 x 5." The patient showed good language comprehension and production abilities, had minimal number transcoding difficulties, and mastered normally multidigit arithmetic procedures. She was submitted to a series of calculation, verification, and number classification tasks. The arithmetic deficit was evident in both recognition and recall tasks, was consistent across testing sessions, and did not vary as a function of the format used for presentation of the problems. The patient failed even when only implicit access to arithmetic facts was expected: In a timed addition verification task, she did not show a normal inhibition effect when rejecting addition problems in which the proposed result was the product of the two operands (e.g., "3 + 4 = 12"). We suggest that the deficit resulted from a specific and permanent degradation of some connections and nodes in arithmetic long-term memory.

Adult↗

Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.

Scopolamine (3 mg/kg IP) given before an acquisition trial, reduced the retention of a one-trial passive avoidance "step through" response in mice. A single administration of cholinergic agonists such as oxotremorine, BM-5, or arecoline, antagonized this amnesic effect of scopolamine. A significant anti-amnesic effect was also found with nootropic drugs such as piracetam and ucb L059, whereas ucb L060 (the enantiomer of ucb L059), oxiracetam and rolziracetam were shown to be ineffective. Moreover, ucb L059, administered twice daily for 3 days, counteracted the amnesic effects of scopolamine completely, whereas ucb L060 was again inactive. The results demonstrate that: (a) this model of impaired cognition by scopolamine is able to discriminate between closely related chemical substances and even stereoisomers; and (b) nootropic drugs, such as ucb L059, are more effective after repeated rather than after acute administration.

Amnesia↗

Reversal of scopolamine-induced amnesia by phosphatidylserine in rats.

Scopolamine (2 mg/kg IP) and propranolol (55 mg/kg IP), given before a single learning trial, reduce retention of a passive avoidance response in rats. Phosphatidylserine, 30-60 mg/kg IP, antagonizes the amnesic effect of scopolamine but not that of propranolol. The retention of the passive avoidance response is not affected by phosphatidylserine given alone. The results indicate that this phospholipid selectively counteracts the action of scopolamine on passive avoidance acquisition, probably via a cholinergic mechanism.

Amnesia↗